Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:5:3136.
doi: 10.1038/ncomms4136.

Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa

Affiliations
Free PMC article

Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa

Jamie T Griffin et al. Nat Commun. 2014.
Free PMC article

Abstract

Estimating the changing burden of malaria disease remains difficult owing to limitations in health reporting systems. Here, we use a transmission model incorporating acquisition and loss of immunity to capture age-specific patterns of disease at different transmission intensities. The model is fitted to age-stratified data from 23 sites in Africa, and we then produce maps and estimates of disease burden. We estimate that in 2010 there were 252 (95% credible interval: 171-353) million cases of malaria in sub-Saharan Africa that active case finding would detect. However, only 34% (12-86%) of these cases would be observed through passive case detection. We estimate that the proportion of all cases of clinical malaria that are in under-fives varies from above 60% at high transmission to below 20% at low transmission. The focus of some interventions towards young children may need to be reconsidered, and should be informed by the current local transmission intensity.

PubMed Disclaimer

Conflict of interest statement

A.C.G. was paid by GlaxoSmithKline to attend a single advisory board meeting in December 2009 on how to develop models for the economic evaluation of RTSS. Currently she has a collaborative agreement with GlaxoSmithKline to re-analyse RTSS Phase II trial data, which is managed via the Imperial College, but does not involve monetary exchange and under which the company does not have final decision on publication. None of these activities relates to this article. All other authors have declared that no competing interests exist

Figures

Figure 1
Figure 1. Incidence of clinical malaria in 0–5 year olds plotted against prevalence.
Solid symbols indicate studies in which both clinical incidence and parasite prevalence were reported; hollow symbols indicate studies in which only clinical incidence is reported and parasite prevalence was estimated from alternative data (based on the prior EIR). The legend states the country, and also the place and year(s) where necessary to identify the study. Units for incidence are episodes per person per year.
Figure 2
Figure 2. Observed and fitted incidence of clinical malaria by age.
(aw) Model fits are the median and 95% interval of the predicted incidence over the joint posterior distribution of the parameters and study-specific random effects. Sites are labelled by country and place, with the study year(s) to distinguish studies in the same place. Plots are ordered by posterior EIR. The blue solid symbols are the observed data; the green lines and shaded areas are the fitted model with 95% credible intervals; and the hollow orange symbols are the fitted model averaged over the age groups in the observed data.
Figure 3
Figure 3. Fitted incidence and age distribution of cases plotted against prevalence.
(a) The estimated relationship between parasite prevalence in 2–10 year olds and clinical incidence of disease in 0–5 years olds. The shaded areas represent the 95% credible intervals. (b) The estimated relationship between parasite prevalence in 2–10 year olds and overall clinical incidence (red solid line). The green dashed line shows the relationship estimated in Patil et al. (c) The shifting age-burden of disease at different levels of endemicity. The figure shows the estimated proportion of cases in each age group plotted against prevalence. (d) The estimated relationship between prevalence and clinical disease incidence in 0–5 year olds by detection method: blue—daily ACD; dark green—weekly ACD; orange—PCD. Lines are model predictions; solid symbols are observed incidence and prevalence; hollow symbols are observed incidence and model-fitted prevalence (based on the prior EIR).
Figure 4
Figure 4. Age distribution of cases across Africa.
(a) 0–5 years old; (b) 5–15 years old; (c) over 15 years old.
Figure 5
Figure 5. The relationship between incidence and prevalence, if transmission has recently declined.
Panels show (a) incidence in under-fives against prevalence in 2–10 year olds, and (b) the proportion of cases in under-fives, following a change in transmission. (c) The prevalence before the decline in EIR plotted against current prevalence. Each coloured line is for a different reduction in EIR over the previous 10 years from 0 to 90%, as marked in panel c.
Figure 6
Figure 6. Model flow diagram.
S, susceptible, D, clinical disease, A, asymptomatic patent infection, U, subpatent infection, T, treated and P, prophylaxis. The parameters are defined in the text.

Similar articles

Cited by

References

    1. O’Meara W. P., Mangeni J. N., Steketee R. & Greenwood B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect. Dis. 10, 545–555 (2010). - PubMed
    1. Carneiro I. et al.. Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS One 5, e8988 (2010). - PMC - PubMed
    1. Brasseur P. et al.. Changing patterns of malaria during 1996-2010 in an area of moderate transmission in southern Senegal. Malar. J. 10, 203 (2011). - PMC - PubMed
    1. Ceesay S. J. et al.. Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 372, 1545–1554 (2008). - PMC - PubMed
    1. Littrell M. et al.. Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Malar. J. 10, 327 (2011). - PMC - PubMed

Publication types